BETAHISTINE-ZP betahistine dihydrochloride 8mg tablets blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

betahistine dihydrochloride, Quantity: 8 mg

Mevcut itibaren:

Medis Pharma Pty Ltd

INN (International Adı):

betahistine dihydrochloride

Farmasötik formu:

Tablet

Kompozisyon:

Excipient Ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose

Uygulama yolu:

Oral

Paketteki üniteler:

100 tablets, 10 tablets, 25 tablets

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Ürün özeti:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B8 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2015-11-10